SuzanneJaneBaronMDMSc
Cardiology • Boston, MAInterventional Cardiology
Director of Interventional Cardiology Research
Dr. Baron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114
Summary
- Dr. Suzanne Baron is a cardiologist in Boston, MA and is affiliated with Massachusetts General Hospital. She received her medical degree from Yale University School of Medicine and has been in practice 12 years. She specializes in interventional cardiology and is experienced in structural heart disease.
Education & Training
Massachusetts General HospitalStructural Heart Disease, 2013 - 2014- Massachusetts General HospitalFellowship, Interventional Cardiology, 2011 - 2012
- Massachusetts General HospitalFellowship, Cardiovascular Disease, 2008 - 2011
- Massachusetts General HospitalResidency, Internal Medicine, 2005 - 2008
Yale School of MedicineClass of 2005
Certifications & Licensure
NH State Medical License 2013 - Present
MA State Medical License 2007 - 2025
KS State Medical License 2014 - 2020
MO State Medical License 2014 - 2020- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 132 citationsCost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid CardiomyopathyDhruv S. Kazi, Brandon K. Bellows, Suzanne J. Baron, Changyu Shen, David J. Cohen
Circulation. 2020-04-14 - 84 citationsImpact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.Suzanne J. Baron, Suzanne V. Arnold, Howard C. Herrmann, David R. Holmes, Wilson Y. Szeto
Journal of the American College of Cardiology. 2016-05-24 - 36 citationsTricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.Rebecca T Hahn, Matthew K Lawlor, Charles J Davidson, Vinay Badhwar, Anna Sannino
Journal of the American College of Cardiology. 2023-10-24
Journal Articles
- Original Investigation Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER TrialEugene H Blackstone, Vinod H Thourani, Howard C Herrmann, David J Cohen, Martin B Leon, Michael J Mack, Raj R Makkar, Samir R Kapadia, Susheel K Kodali, Lars G Svensso..., ScienceDirect
- Focus on Tricuspid, Mitral, and Aortic Valve Interventions Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients with Severe Aortic Stenosis...Susheel Kodali, Craig R Smith, Suzanne J Baron, Augusto D Pichard, Elizabeth A Magnuson, Howard C Herrmann, Vinod H Thourani, Vasilis Babaliaros, Kevin Greason, David ..., ScienceDirect
- Quality of Life After Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main DiseaseSuzanne Baron, MD, ScienceDirect
Press Mentions
SCAI Announces 2023-24 SCAI-WIN CHIP Fellowship RecipientMay 21st, 2023- A Call to Revamp Revascularization Trial EndpointsMay 8th, 2023
- COAPT 5-Year Results ‘Remarkable’ However (*64*) Issues RemainMarch 30th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
